Gilead expects big increase in Europe... - HFI Connect - Hep...

HFI Connect - Hepatitis

959 members1,215 posts

Gilead expects big increase in Europeans treated with hep C drug

mwright profile image
0 Replies

Gilead Sciences Inc said on Tuesday it expects the number of hepatitis C patients treated in Europe with its Sovaldi drug to increase dramatically this year, and that approvals for the newer combination pill, Harvoni, could come quickly. Read more here bit.ly/1A0aAZA

Written by
mwright profile image
mwright
To view profiles and participate in discussions please or .
Read more about...